Asahi Kasei Corporation (TYO:3407)
1,119.50
0.00 (0.00%)
Aug 14, 2025, 3:30 PM JST
Asahi Kasei Revenue
Asahi Kasei had revenue of 738.32B JPY in the quarter ending June 30, 2025, with 0.32% growth. This brings the company's revenue in the last twelve months to 3.04T, up 5.91% year-over-year. In the fiscal year ending March 31, 2025, Asahi Kasei had annual revenue of 3.04T with 9.06% growth.
Revenue (ttm)
3,039.70B
Revenue Growth
+5.91%
P/S Ratio
0.50
Revenue / Employee
60.37M
Employees
50,352
Market Cap
1,520.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 3,037.31B | 252.43B | 9.06% |
Mar 31, 2024 | 2,784.88B | 58.39B | 2.14% |
Mar 31, 2023 | 2,726.49B | 265.17B | 10.77% |
Mar 31, 2022 | 2,461.32B | 355.27B | 16.87% |
Mar 31, 2021 | 2,106.05B | -45.60B | -2.12% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shin-Etsu Chemical | 2,591.87B |
Nippon Steel | 8,512.77B |
Nippon Paint Holdings | 1,674.01B |
Nippon Sanso Holdings | 1,293.51B |
Nitto Denko | 1,010.76B |
JFE Holdings | 4,763.82B |
Mitsubishi Chemical Group | 4,271.06B |
Sumitomo Metal Mining | 1,562.65B |
Asahi Kasei News
- 9 days ago - Asahi Kasei Successfully Demonstrates Biomethane Production with High Yield and High Purity Using Biogas from Organic Waste - Business Upturn
- 14 days ago - Asahi Kasei to Supply Hipore™ Lithium-Ion Battery Separator to Toyota Tsusho - Business Wire
- 16 days ago - Asahi Kasei Expands Planova™ Production with New Spinning Plant, Strengthening Life Science's Global Bioprocess Supply Capabilities - Business Wire
- 6 weeks ago - Asahi Kasei Pharma Starts Phase III Study of Promising CIPN Prevention Therapy, ART-123 (Recomodulin™), to Enhance Treatment Options Worldwide - Business Wire
- 2 months ago - Asahi Kasei Receives Imperial Invention Prize in Japan for Nickel-Coated Absorption Layer - Mitigating the Deterioration of Electrodes and Contributing to a Stable, Long-Term Electrolyzer Operation - Business Wire
- 2 months ago - Asahi Kasei Launches New Series of Sunfort™ Dry Film Photoresist as Material for Back-End Processing of Advanced Semiconductor Packaging Used in AI Servers - Business Wire
- 3 months ago - Asahi Kasei Microdevices and Dirac Partner to Meet Growing Demand for High-Fidelity In-Car Audio Performance - Business Wire
- 3 months ago - Asahi Kasei Bioprocess America and PeptiSystems Announce Global Partnership in Peptide Manufacturing—Streamlining the Peptide Processing Market. - Business Wire